Daniel R. Marshall - Concepedia

Author

Daniel R. Marshall

Boehringer Ingelheim (United States)ORCID

Also Known As

D Marshall, D. MARSHALL, D. Marshall, D. R. MARSHALL, D. R. Marshall, Daniel Marshall, Daniel R. Marshall, Delis Suzan Marshall

Publications

760

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (United States)

About

Daniel R. Marshall is an author at Boehringer Ingelheim (United States) specializing in medicinal chemistry, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	75
2	Natural Sciences	4	4	75
3	Biochemistry	4	4	75
4	Engineering	2	2	348
5	Health Sciences	1	1	81

Daniel R. Marshall

Publications

591

Citations

H-Index

Page 1

	Year	Citations
Palladium-catalyzed coupling of arylstannanes with organic sulfonates: a comprehensive study Vittorio Farina, Bala Krishnan, Daniel R. Marshall, The Journal of Organic Chemistry Gregory P. RothcitePalladium-catalyzed CouplingChemical EngineeringCross-coupling ReactionEngineering	1993	249
Efficient Pd-Catalyzed Heterobenzylic Cross-Coupling Using Sulfonium Salts as Substrates and (PhO)<sub>3</sub>P as a Supporting Ligand Shijie Zhang, Daniel R. Marshall, Lanny S. Liebeskind The Journal of Organic Chemistry Chemical EngineeringCross-coupling ReactionEngineeringAlkene MetathesisPalladium-catalyzed Cross-coupling	1999	99
The problem of calcium requirement B. E. C. Nordin, K J Polley, A. G. Need, American Journal of Clinical Nutrition NutritionElectrolyte DisorderNutritional RequirementPhysiologyClinical Nutrition	1987	81
Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β: Part I: Hit-to-Lead Strategies Tina M. Morwick, Angela Berry, Janice R. Brickwood, Journal of Medicinal Chemistry	2006	67
The discovery of thienopyridine analogues as potent IκB kinase β inhibitors. Part II Jiang‐Ping Wu, Roman Fleck, Janice R. Brickwood, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2009	32
BI 5700, a Selective Chemical Inhibitor of I B Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression Margit A. Huber, Helena J. Maier, Memetcan Alacakaptan, Genes & Cancer	2010	20
α-Methyltryptamine sulfonamide derivatives as novel glucocorticoid receptor ligands Daniel R. Marshall, Gus Rodriguez, David Thomson, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal Chemistryα-Methyltryptamine Sulfonamide DerivativesDerivativesBiochemistry	2006	18
Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase Tina M. Morwick, Frank Büttner, Charles L. Cywin, Journal of Medicinal Chemistry Drug TargetHit IdentificationHigh ThroughputLead IdentificationPharmacotherapy	2009	13
Dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity Kenneth M. Meyers, Derek A. Cogan, Jennifer Burke, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNovel Selective Inhibitors	2017	12

Page 1